Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: megestrol
What it is used for
Palliative treatment of recurrent inoperable or metastatic carcinoma of the breast (see DOSAGE). It should not be used in lieu of currently accepted procedures such as surgery, radiation or chemotherapy.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 30 degrees Celsius
- Shelf lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
White, oval bicovex tablet 17mm x 8 mm embossed 160 on 1 side, scored other side
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
This medicine contains the active ingredients:
If you are over 65 years of age, there may be specific risks and recommendations for use of this medicine. Please discuss your individual circumstances with your pharmacist, doctor or health professional. For more information read our page on medication safety for older people.
Pregnant or planning a pregnancy?
For the active ingredient megestrol
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Megace Tablets - myDr.com.au
Megace Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Types of hormonal therapy | Cancer Australia
There are different types of hormonal therapy for breast cancer. The type of hormonal therapy recommended for women with hormone receptor-positive breast cancer depends on whether the woman has reached menopause
Read more on Cancer Australia website